Drawing for TREXIOCEL

USPTO serial 79232497

TREXIOCEL

Reviewed by CopyMark Law Group

Reg. 5682721Status 709
Filing date
Status date
Registration date
Feb 26, 2019
Examiner
MIRANDA, JOHN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TREXIOCEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia W. Stangle

Claudia W. Stangle Leydig, Voit & Mayer, Ltd.Two Prudential Plaza, 180 N. Stetson AveSuire 4900Chicago, IL 60601

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products in the nature of pharmaceutical preparations for the treatment, alleviation and healing of peripheral arterial diseases and wounds including peripheral arterial shutter-illness and diabetic foot ulcers; pharmaceutical products in the nature of pharmaceutical preparations for tissue repair and tissue regenerationSECTION 71 - CANCELLED—
042Development of pharmaceutical preparations and substances in the nature of medicines; scientific and technological services in the nature of analysis and research in the field of pharmaceuticals; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals and scientific and technological analysis in the field of pharmaceuticalsSECTION 71 - CANCELLED—
044Medical servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 12, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 12, 2025C71TCANCELLED SECTION 71—
Feb 26, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 5, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 15, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 15, 2019FIMPFINAL DISPOSITION PROCESSED—
May 26, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 8, 2018GPNXNOTIFICATION PROCESSED BY IB—
Nov 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 1, 2018ALIEASSIGNED TO LIE—
Oct 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 17, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 11, 2018CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 10, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 30, 2018RFNPREFUSAL PROCESSED BY IB—
Jun 11, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 11, 2018RFRRREFUSAL PROCESSED BY MPU—
Jun 2, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 1, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 25, 2018DOCKASSIGNED TO EXAMINER—
May 25, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 24, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance